Ranking 16th in the Global Innovation Index 2022, Israel continues to lead the region when it comes to creative and technology-driven outputs. The Israeli market has consistently matured and is open more than ever to foreign companies and investment, particularly in the pharmaceutical and medical industries. However, Chinese investment in...
Read more
Ranking 16th in the Global Innovation Index 2022, Israel continues to lead the region when it comes to creative and technology-driven outputs. The Israeli market has consistently matured and is open more than ever to foreign companies and investment, particularly in the pharmaceutical and medical industries. However, Chinese investment in the country has plateaued since its peak in 2018. The multiple electoral changes in recent years have led to a stagnation in legislative changes, which has affected the patent world. Nevertheless, in August 2022 the Israeli parliament approved a bill amending the Patents Law, which aimed to introduce statistical process control manufacturing and stockpiling waivers. The amendment intends to increase competition in the Israeli pharmaceutical industry to become more aligned with international markets, particularly within the European Union. Some practitioners worry about the potential impact of this amendment on pharmaceutical patents.
Show less
